PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,017,572 | -43.9% | 121,865 | -10.6% | 0.00% | 0.0% |
| Q2 2023 | $1,813,389 | +783.1% | 136,345 | +668.9% | 0.00% | – |
| Q1 2023 | $205,337 | +28.3% | 17,732 | -9.4% | 0.00% | – |
| Q4 2022 | $160,074 | -78.3% | 19,569 | -84.6% | 0.00% | – |
| Q3 2022 | $736,000 | +271.7% | 126,755 | +182.2% | 0.00% | – |
| Q2 2022 | $198,000 | -84.7% | 44,909 | -68.4% | 0.00% | -100.0% |
| Q1 2022 | $1,294,000 | -27.4% | 142,281 | +63.2% | 0.00% | 0.0% |
| Q4 2021 | $1,783,000 | +13.1% | 87,166 | +41.2% | 0.00% | 0.0% |
| Q3 2021 | $1,577,000 | -11.3% | 61,711 | +21.5% | 0.00% | 0.0% |
| Q2 2021 | $1,777,000 | +79.5% | 50,805 | +71.0% | 0.00% | 0.0% |
| Q1 2021 | $990,000 | -42.5% | 29,710 | -55.2% | 0.00% | 0.0% |
| Q4 2020 | $1,722,000 | +720.0% | 66,378 | +211.5% | 0.00% | – |
| Q3 2020 | $210,000 | +12.3% | 21,307 | -60.8% | 0.00% | – |
| Q2 2020 | $187,000 | +17.6% | 54,317 | +4.6% | 0.00% | – |
| Q1 2020 | $159,000 | -30.3% | 51,939 | +17.0% | 0.00% | – |
| Q4 2019 | $228,000 | -74.9% | 44,395 | -74.8% | 0.00% | -100.0% |
| Q3 2019 | $908,000 | -42.1% | 175,860 | -32.1% | 0.00% | 0.0% |
| Q2 2019 | $1,568,000 | -90.4% | 259,092 | -88.5% | 0.00% | -93.8% |
| Q1 2019 | $16,346,000 | +35.1% | 2,260,823 | +38.2% | 0.02% | +33.3% |
| Q4 2018 | $12,102,000 | +4760.2% | 1,635,359 | +3459.5% | 0.01% | – |
| Q3 2018 | $249,000 | +183.0% | 45,943 | +84.8% | 0.00% | – |
| Q2 2018 | $88,000 | +319.0% | 24,861 | +135.5% | 0.00% | – |
| Q1 2018 | $21,000 | -43.2% | 10,558 | -25.1% | 0.00% | – |
| Q4 2017 | $37,000 | -62.2% | 14,090 | -24.1% | 0.00% | – |
| Q3 2017 | $98,000 | +71.9% | 18,563 | +14.7% | 0.00% | – |
| Q2 2017 | $57,000 | -20.8% | 16,179 | +16.3% | 0.00% | – |
| Q1 2017 | $72,000 | -67.3% | 13,917 | -76.0% | 0.00% | – |
| Q4 2016 | $220,000 | -29.3% | 57,950 | +67.0% | 0.00% | – |
| Q3 2016 | $311,000 | +27.5% | 34,710 | +0.6% | 0.00% | – |
| Q2 2016 | $244,000 | -57.6% | 34,520 | -49.0% | 0.00% | -100.0% |
| Q1 2016 | $575,000 | +55.8% | 67,717 | +140.5% | 0.00% | – |
| Q4 2015 | $369,000 | +1217.9% | 28,156 | +271.0% | 0.00% | – |
| Q3 2015 | $28,000 | -67.4% | 7,589 | -48.8% | 0.00% | – |
| Q2 2015 | $86,000 | -34.4% | 14,832 | -34.0% | 0.00% | – |
| Q1 2015 | $131,000 | -37.6% | 22,479 | -16.2% | 0.00% | – |
| Q4 2014 | $210,000 | +1515.4% | 26,827 | +963.3% | 0.00% | – |
| Q3 2014 | $13,000 | -60.6% | 2,523 | -53.9% | 0.00% | – |
| Q2 2014 | $33,000 | -53.5% | 5,478 | -58.5% | 0.00% | – |
| Q1 2014 | $71,000 | -42.3% | 13,211 | -43.8% | 0.00% | – |
| Q4 2013 | $123,000 | +3.4% | 23,487 | +9.2% | 0.00% | – |
| Q3 2013 | $119,000 | +138.0% | 21,507 | +8.3% | 0.00% | – |
| Q2 2013 | $50,000 | – | 19,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |